191 related articles for article (PubMed ID: 25182063)
1. In vitro activities of the novel bicyclolides modithromycin (EDP-420, EP-013420, S-013420) and EDP-322 against MDR clinical Neisseria gonorrhoeae isolates and international reference strains.
Jacobsson S; Golparian D; Phan LT; Ohnishi M; Fredlund H; Or YS; Unemo M
J Antimicrob Chemother; 2015 Jan; 70(1):173-7. PubMed ID: 25182063
[TBL] [Abstract][Full Text] [Related]
2. High in vitro activity of a novel dual bacterial topoisomerase inhibitor of the ATPase activities of GyrB and ParE (VT12-008911) against Neisseria gonorrhoeae isolates with various high-level antimicrobial resistance and multidrug resistance.
Jeverica S; Golparian D; Hanzelka B; Fowlie AJ; Matičič M; Unemo M
J Antimicrob Chemother; 2014 Jul; 69(7):1866-72. PubMed ID: 24651828
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of the novel oral antimicrobial SMT-571, with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae: future treatment option for gonorrhoea?
Jacobsson S; Mason C; Khan N; Meo P; Unemo M
J Antimicrob Chemother; 2019 Jun; 74(6):1591-1594. PubMed ID: 30778550
[TBL] [Abstract][Full Text] [Related]
4.
Li X; Le W; Lou X; Wang B; Genco CA; Rice PA; Su X
Microbiol Spectr; 2021 Oct; 9(2):e0018121. PubMed ID: 34668731
[TBL] [Abstract][Full Text] [Related]
5. Treatment failure with 2 g of azithromycin (extended-release formulation) in gonorrhoea in Japan caused by the international multidrug-resistant ST1407 strain of Neisseria gonorrhoeae.
Morita-Ishihara T; Unemo M; Furubayashi K; Kawahata T; Shimuta K; Nakayama S; Ohnishi M
J Antimicrob Chemother; 2014 Aug; 69(8):2086-90. PubMed ID: 24777907
[TBL] [Abstract][Full Text] [Related]
6. High in vitro activity of DIS-73285, a novel antimicrobial with a new mechanism of action, against MDR and XDR Neisseria gonorrhoeae.
Jacobsson S; Mason C; Khan N; Meo P; Unemo M
J Antimicrob Chemother; 2020 Nov; 75(11):3244-3247. PubMed ID: 32712655
[TBL] [Abstract][Full Text] [Related]
7. High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.
Unemo M; Ringlander J; Wiggins C; Fredlund H; Jacobsson S; Cole M
Antimicrob Agents Chemother; 2015 Sep; 59(9):5220-5. PubMed ID: 26077246
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea?
Unemo M; Golparian D; Limnios A; Whiley D; Ohnishi M; Lahra MM; Tapsall JW
Antimicrob Agents Chemother; 2012 Jul; 56(7):3603-9. PubMed ID: 22547617
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae.
Jacobsson S; Golparian D; Scangarella-Oman N; Unemo M
J Antimicrob Chemother; 2018 Aug; 73(8):2072-2077. PubMed ID: 29796611
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity and time-kill curve analysis of sitafloxacin against a global panel of antimicrobial-resistant and multidrug-resistant Neisseria gonorrhoeae isolates.
Jönsson A; Foerster S; Golparian D; Hamasuna R; Jacobsson S; Lindberg M; Jensen JS; Ohnishi M; Unemo M
APMIS; 2018 Jan; 126(1):29-37. PubMed ID: 29154480
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
Boiko I; Golparian D; Krynytska I; Bezkorovaina H; Frankenberg A; Onuchyna M; Jacobsson S; Unemo M
APMIS; 2019 Jul; 127(7):503-509. PubMed ID: 30903707
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential.
Lagacé-Wiens PRS; Adam HJ; Laing NM; Baxter MR; Martin I; Mulvey MR; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2017 Aug; 72(8):2273-2277. PubMed ID: 28505331
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared to Calibrated Dichotomous Sensitivity and Clinical Laboratory Standards Institute disc diffusion techniques.
Mal PB; Jabeen K; Farooqi J; Unemo M; Khan E
BMC Microbiol; 2016 Oct; 16(1):236. PubMed ID: 27724873
[TBL] [Abstract][Full Text] [Related]
14. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution.
Wind CM; de Vries HJ; van Dam AP
Int J Antimicrob Agents; 2015 Mar; 45(3):305-8. PubMed ID: 25532741
[TBL] [Abstract][Full Text] [Related]
15.
Jacobsson S; Alirol E; Unemo M
J Chemother; 2019 Sep; 31(5):246-251. PubMed ID: 31106713
[TBL] [Abstract][Full Text] [Related]
16. Comparison of E-test with agar dilution methods in testing susceptibility of N. gonorrhoeae to azithromycin.
Yasin RM; Suan KA; Meng CY
Sex Transm Dis; 1997 May; 24(5):257-60. PubMed ID: 9153733
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.
Starnino S; ; Galarza P; Carvallo ME; Benzaken AS; Ballesteros AM; Cruz OM; Hernandez AL; Carbajal JL; Borthagaray G; Payares D; Dillon JA
Sex Transm Dis; 2012 Oct; 39(10):813-21. PubMed ID: 23001269
[TBL] [Abstract][Full Text] [Related]
18. Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.
Hottes TS; Lester RT; Hoang LM; McKay R; Imperial M; Gilbert M; Patrick D; Wong T; Martin I; Ogilvie G
Sex Transm Dis; 2013 Jan; 40(1):46-51. PubMed ID: 23250301
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of and factors associated with MDR Neisseria gonorrhoeae in England and Wales between 2004 and 2015: analysis of annual cross-sectional surveillance surveys.
Clifton S; Bolt H; Mohammed H; Town K; Furegato M; Cole M; Campbell O; Fifer H; Hughes G
J Antimicrob Chemother; 2018 Apr; 73(4):923-932. PubMed ID: 29394396
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany.
Enders M; Turnwald-Maschler A; Regnath T
Eur J Clin Microbiol Infect Dis; 2006 May; 25(5):318-22. PubMed ID: 16733613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
